课题基金 / 基金详情

CANINE OSTEOSARCOMA CELLS EXPRESS MMP-9 THROUGH CELL-MATRIX

CANINE OSTEOSARCOMA CELLS EXPRESS MMP-9 THROUGH CELL-MATRIX
犬骨肉瘤细胞通过细胞基质表达 MMP-9
批准号:
10660280
负责人:
ARAI Katsuhiko
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

ARAI Katsuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
为了探讨MMP-9在肺转移形成中的作用,我们通过将骨肉瘤细胞注射到SCID小鼠乳腺衬垫,建立了肺转移动物模型。明胶酶谱图显示含有转移灶的肺组织分泌大量MMP-9,而在“假设”起源中仅检测到MMP-2,这些结果表明OS细胞在肿瘤侵袭和转移过程中可以获得MMP-9的表达能力。因此,我们在几种体外培养条件下考察了MMP-9的表达机制。在多种细胞外基质上单层培养的OS细胞中,明胶酶谱法未检测到MMP-9,而MMP-2持续表达。当OS细胞在I型胶原凝胶中培养时,除了MMP-2外,还明显检测到MMP-9。抗整合素抗体和细胞松弛素d可下调胶原凝胶中MMP-9的表达,因此,我们认为OS细胞中MMP-9的表达是通过整合素介导的细胞-基质相互作用和肌动蛋白聚合来调节的。
英文摘要
To investigate the participation of MMP-9 in the formation of lung metastasis, we have established an animal model for lung metastasis by the injection of osteosarcoma (OS) cells into mammary fad pad of SCID mice. Gelatinzymography revealed a great deal of MMP-9 secreted by the lung tissues containing metastatic lesions, whereas only MMP-2 was detected in 'hypothetic' origin these results suggested that OS cells could acquire the ability of MMP-9 expression during tumor invasion and metastasis. Therefore, we examined the mechanism of MMP-9 expression under several culture condition in vitro. In monolayer culture of OS cells on several extracellular matrix, MMP-9 was not detected by gelatin zymography, while MMP-2 was constantly expressed. When OS cells were cultivated in type I collagen gel, MMP-9 was apparently detected in addition of MMP-2. The expression of MMP-9 in collagen gel was down-regulated by anti-integrin antibodies and cytochalasin D. Thus, we suggested that the expression of MMP-9 by OS cells was regulated through integrin-mediated cell-matrix interaction and following actin polymerization.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Ohshima K, Kishi H, Itoh M, Watanabe G, Arai K, Uehara K, Groome NP, Taya K: "Secrtion of inhibin A, inhibin B and inhibin pro-alphaC during the oestrous cycle of the golden hamster (Mesocricetus auratus)"J. Endocrinol. 162. 451-456 (1999)
Ohshima K、Kishi H、Itoh M、Watanabe G、Arai K、Uehara K、Groome NP、Taya K:“金仓鼠 (Mesocricetus auratus) 发情周期中抑制素 A、抑制素 B 和抑制素前体 αC 的部分”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
TANAKA et al.: "Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation"Blood. 94. 2390-2395 (1999)
TANAKA 等人:“基质金属蛋白酶 9 的产生是肥大细胞祖细胞的一种新发现的功能,可通过 c-kit 受体激活来下调”血液。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
新井 他: "細胞外マトリックス研究法全6巻"コラーゲン技術研修会. 789 (1998)
Arai等人:“细胞外基质研究方法,6卷”胶原技术研讨会789(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K. ARAI., K. OHSHIMA, G. WATANABE, K. ARAI, K. UEHARA, K. TAYA: "Inhibition of ovarian follicular developed associated with a decrease in luterinizing hormone levels during the estrous cycle of the rat"Endocrine J., 1998. 45. 539-546 (1998)
K. ARAI.、K. OHSHIMA、G. WATANABE、K. ARAI、K. UEHARA、K. TAYA:“卵巢卵泡发育的抑制与大鼠动情周期期间黄体生成素水平的降低有关”Endocrine J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Basic reserch for quality management of canine mesenchymal stem cells
    Elucidation of tissue flexibility through morphogenesis of reticular fiber and establishment of new biomarker for meat evaluation
    Analysis of molecular mechanism for modification of p53 tumor suppressor protein by anti-cancer drugs
    Relation ship between the emergence of drug-resistant tumor cells and transformation of β-tubulin isotype mRNA expression
    国内基金
    海外基金
    基于“Healthy-NAT-Tumor”三维度的食管鳞癌蛋白组学数据挖掘及其临床意义研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      刘伟
    • 依托单位:
    超级增强子驱动“CYTOR-FOSL1正反馈环路”促进口腔鳞癌Tumor budding转移的研究
    • 批准号:
      82073265
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2020
    • 负责人:
      王成
    • 依托单位:
    CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
    • 批准号:
      82072862
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2020
    • 负责人:
      徐云升
    • 依托单位:
    STAU1/TP63信号轴介导TINCR调控舌鳞癌tumor budding细胞干性维持
    • 批准号:
      81802704
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2018
    • 负责人:
      庄泽航
    • 依托单位: